DE602005015486D1 - Esterderivate von ascorbinsäure und 2-ketosäuresacchariden - Google Patents

Esterderivate von ascorbinsäure und 2-ketosäuresacchariden

Info

Publication number
DE602005015486D1
DE602005015486D1 DE602005015486T DE602005015486T DE602005015486D1 DE 602005015486 D1 DE602005015486 D1 DE 602005015486D1 DE 602005015486 T DE602005015486 T DE 602005015486T DE 602005015486 T DE602005015486 T DE 602005015486T DE 602005015486 D1 DE602005015486 D1 DE 602005015486D1
Authority
DE
Germany
Prior art keywords
ketosuresaccharidene
ascorbic acid
ester derivatives
derivatives
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015486T
Other languages
English (en)
Inventor
Joseph C Mcauliffe
Wyatt Charles Smith
Michael S Starch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Corp
Original Assignee
Dow Corning Corp
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Corp, Genencor International Inc filed Critical Dow Corning Corp
Publication of DE602005015486D1 publication Critical patent/DE602005015486D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/38—Polysiloxanes modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/38—Polysiloxanes modified by chemical after-treatment
    • C08G77/382—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon
    • C08G77/395—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon containing phosphorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Silicon Polymers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005015486T 2004-12-16 2005-12-16 Esterderivate von ascorbinsäure und 2-ketosäuresacchariden Active DE602005015486D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63656704P 2004-12-16 2004-12-16
PCT/US2005/045991 WO2006066227A2 (en) 2004-12-16 2005-12-16 Ester derivatives of ascorbic and 2-keto acid saccharides

Publications (1)

Publication Number Publication Date
DE602005015486D1 true DE602005015486D1 (de) 2009-08-27

Family

ID=36579770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015486T Active DE602005015486D1 (de) 2004-12-16 2005-12-16 Esterderivate von ascorbinsäure und 2-ketosäuresacchariden

Country Status (6)

Country Link
US (1) US7871987B2 (de)
EP (1) EP1833881B1 (de)
JP (1) JP5214974B2 (de)
CN (1) CN101080436B (de)
DE (1) DE602005015486D1 (de)
WO (1) WO2006066227A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006071772A2 (en) 2004-12-23 2006-07-06 Dow Corning Corporation Crosslinkable saccharide-siloxane compositions, and networks, coatings and articles formed therefrom
WO2006127883A2 (en) * 2005-05-23 2006-11-30 Dow Corning Corporation Personal care compositions comprising saccharide-siloxane copolymers
ATE486165T1 (de) * 2005-05-23 2010-11-15 Dow Corning Oberflächenbehandlungszusammensetzungen mit saccharid-siloxan-polymeren
KR101460980B1 (ko) 2006-05-23 2014-11-13 다우 코닝 코포레이션 활성제를 전달하기 위한 신규한 실리콘막 형성제
WO2008046763A1 (en) * 2006-10-20 2008-04-24 L'oreal Cosmetic composition comprising a siloxane-saccharide copolymer
US8278288B2 (en) 2007-09-28 2012-10-02 Dow Corning Corporation Organosiloxanes containing ester derivatives of ascorbic acid
US8071514B2 (en) 2008-03-07 2011-12-06 Exxonmobil Chemical Patents Inc. Silicone functionalized fluids with low traction characteristics
US8163300B2 (en) * 2008-03-07 2012-04-24 Exxonmobil Chemical Patents Inc. Method for enhancing dispersion of inorganic compounds using silicone-containing esters and compositions formed therefrom
US8034363B2 (en) * 2008-12-11 2011-10-11 Advanced Technologies And Regenerative Medicine, Llc. Sustained release systems of ascorbic acid phosphate
CN101550119B (zh) * 2009-05-11 2012-05-30 无锡宏瑞生物医药科技有限公司 芳基(乙)丙酸抗坏血酸酯,其制备方法及含有它们的药物
JP5997155B2 (ja) 2010-08-23 2016-09-28 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 水性環境で安定している糖シロキサン並びにそのような糖シロキサンの調製及び使用方法
US9315631B2 (en) 2012-01-18 2016-04-19 Dow Corning Corporation Methods of making saccharide siloxane copolymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89850A0 (en) * 1988-04-25 1989-12-15 Takeda Chemical Industries Ltd Ester of ascorbic acid 2-phosphate
JPH11106310A (ja) * 1997-09-30 1999-04-20 Shiseido Co Ltd Ｗ／ｏ乳化組成物
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
FR2800073B1 (fr) * 1999-10-26 2001-11-23 Oreal Nouveaux composes silicies derives de l'acide ascorbique, procede de preparation, compositions les comprenant et utilisations
JP4043764B2 (ja) * 2001-11-13 2008-02-06 東レ・ダウコーニング株式会社 糖残基を有するオルガノポリカルボシロキサンおよびその製造方法
JP4043765B2 (ja) * 2001-11-13 2008-02-06 東レ・ダウコーニング株式会社 糖残基を有するオルガノポリシロキサンおよびその製造方法
EP1539777B1 (de) * 2002-08-16 2012-06-06 Dow Corning Corporation Enzymkatalysierte siliziumorganische kohlenwasserstoffe

Also Published As

Publication number Publication date
JP5214974B2 (ja) 2013-06-19
EP1833881B1 (de) 2009-07-15
JP2008524254A (ja) 2008-07-10
US7871987B2 (en) 2011-01-18
EP1833881A2 (de) 2007-09-19
WO2006066227A3 (en) 2006-08-10
WO2006066227A2 (en) 2006-06-22
US20080118454A1 (en) 2008-05-22
CN101080436B (zh) 2010-09-22
CN101080436A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
DE602005015486D1 (de) Esterderivate von ascorbinsäure und 2-ketosäuresacchariden
LTC1761540I2 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE602005016890D1 (de) Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
DE602005011285D1 (de) Formmasse von polymer
DK1871738T3 (da) N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse
ATE398126T1 (de) Azaindolinhibitoren von mtp und apob
ATE425952T1 (de) (biphenyl)carbonsauren und derivate davon
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DE602005023908D1 (de) Zusammensetzungen von polyestern und tonen vom sepiolit-typ
DE602006017256D1 (de) Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel
CR9850A (es) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
ATE523594T1 (de) Modifizierung von pflanzenentwicklung und - morphologie
ATE517098T1 (de) Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
ATE468342T1 (de) Azolopyridin-2-on-derivate als inhibitoren von lipasen und phospholipasen
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE602006007995D1 (de) Formulierungen von liponsäure und hyaluronsäurebeneichen
ATE495163T1 (de) Benzothiazol-2-on-derivate als inhibitoren von lipasen und phospholipasen
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
ATE415948T1 (de) Geschmacksmaskierte formulierung von clarithromycin
ATE443512T1 (de) Pharmazeutische zusammensetzung von piperazinderivaten
ATE497504T1 (de) Aminoderivate von b-homoandrostanen und b- heteroandrostanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DOW CORNING CORP., MIDLAND, MICH., US